Rockwell Medical Reports Third Quarter Results

Go back to Rockwell Medical Reports Third Quarter Results

BTIG Affirms Rockwell Medical Tech (RMTI) at 'Buy'; Still Sees as Undervalued with Two Approved Product

November 8, 2016 1:31 PM EST

BTIG affirms Rockwell Medical Technologies (Nasdaq: RMTI) at Buy with a price target of $12 after the company posted Q3 results on Monday night.

Analyst Ling Wang summarized: Rockwell Medical reported 3Q16 EPS of $(0.09) vs. consensus of $(0.10) and our estimate of $(0.11),... More

BofA/Merrill Lynch Downgrades Rockwell Medical Technologies (RMTI) to Underperform

November 8, 2016 7:09 AM EST

BofA/Merrill Lynch downgraded Rockwell Medical Technologies (NASDAQ: RMTI) from Neutral to Underperform with a price target of $5.00.

For an analyst ratings summary and ratings history on Rockwell Medical Technologies click here. For more ratings news on Rockwell Medical Technologies click here.

Shares of Rockwell Medical Technologies closed at $5.66 yesterday.

... More

Rockwell Medical Technologies (RMTI) Tops Q3 EPS by 1c

November 7, 2016 4:49 PM EST

Rockwell Medical Technologies (NASDAQ: RMTI) reported Q3 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $12.8 million versus the consensus estimate of $15.4 million.

For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.

... More